|
|
| | TETRABENAZINE Basic information |
| Product Name: | TETRABENAZINE | | Synonyms: | 2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-diMethoxy-3-(2-Methylpropyl)-;3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one;Tetrabenazine (Racemate);Tetrabenazine Racemate, >98%;Ro 1-9569 Racemate;TETRABENAZINE RACEMATE;RO 1-9569 RACEMATE;Tetrabenazine Impurity 10;3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2, | | CAS: | 718635-93-9 | | MF: | C19H27NO3 | | MW: | 317.42 | | EINECS: | | | Product Categories: | | | Mol File: | 718635-93-9.mol |  |
| | TETRABENAZINE Chemical Properties |
| Melting point | 125 °C | | Boiling point | 448.9±45.0 °C(Predicted) | | density | 1.12±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: ≥ 3.2 mg/mL (10.08 mM) | | form | Solid | | pka | 6.46±0.40(Predicted) | | color | Light yellow to yellow |
| | TETRABENAZINE Usage And Synthesis |
| Uses | Tetrabenazine is a dopamine depleting medication for the treatment of chorea in Huntington’s disease. | | Definition | ChEBI: 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one is a benzoquinolizine that is 1,2,3,4,4a,9,10,10a-octahydrophenanthrene in which the carbon at position 10a is replaced by a nitrogen and which is substituted by an isobutyl group at position 2, an oxo group at position 3, and methoxy groups at positions 6 and 7. It is a benzoquinolizine, a cyclic ketone and a tertiary amino compound. | | Synthesis | 6,7-Dimethoxy-3,4-dihydroisoquinoline hydrochloride (118.2 kg) was dissolved in water (3 volumes). A solution of 3-((dimethylamino)methyl)-5-methylhexan-2-one (99.1 kg) in n-heptane (1.5 vol) was added, and the reaction mixture was stirred vigorously at 35 °C for at least 48 hours until the amount of 6,7-dimethoxy-3,4-dihydroisoquinoline was reduced to less than 10% of the initial amount (as detected by a standard solution). After completion of the reaction, the solid product was collected by filtration, washed sequentially with water and n-heptane, and then dried under vacuum to afford 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one (141.1 kg, 85.6% yield). | | References | [1] Patent: US2017/183346, 2017, A1. Location in patent: Paragraph 0165
[2] Patent: US2017/183346, 2017, A1. Location in patent: Paragraph 0162; 0164
[3] Patent: CN107698582, 2018, A. Location in patent: Paragraph 0019
[4] Journal of Labelled Compounds and Radiopharmaceuticals, 2011, vol. 54, # 7, p. 367 - 370 |
| | TETRABENAZINE Preparation Products And Raw materials |
| Raw materials | N-[2-(3,4-dimethoxyphenyl)ethyl]formamide-->(2-Acetyl-4-Methylpentyl)triMethylaMMoniuM Iodide-->3-(N,N-Dimethylaminomethyl)-5-methyl-2-hexanone-->6,7-Dimethoxy-3,4-dihydroisoquinoline-->9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one-->6,7-Dimethoxy-3,4-dihydroisoquinoline hydrochloride-->Methanol-->6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE-->3,4-Dimethoxyphenethylamine |
|